Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model.
<h4>Background</h4>Over 14 million people die each year from infectious diseases despite extensive vaccine use [1]. The needle and syringe--first invented in 1853--is still the primary delivery device, injecting liquid vaccine into muscle. Vaccines could be far more effective if they wer...
Guardado en:
Autores principales: | Germain J P Fernando, Xianfeng Chen, Tarl W Prow, Michael L Crichton, Emily J Fairmaid, Michael S Roberts, Ian H Frazer, Lorena E Brown, Mark A F Kendall |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/513f0894b14147b3946ebd930b55e4f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.
por: Anwar M Hashem, et al.
Publicado: (2009) -
EGF and curcumin co-encapsulated nanoparticle/hydrogel system as potent skin regeneration agent
por: Li X, et al.
Publicado: (2016) -
A framework to guide dose & regimen strategy for clinical drug development
por: Oliver Sander, et al.
Publicado: (2021) -
Potent sialic acid inhibitors that target influenza A virus hemagglutinin
por: Yu-Jen Chang, et al.
Publicado: (2021) -
Network-Guided Discovery of Influenza Virus Replication Host Factors
por: Emily E. Ackerman, et al.
Publicado: (2018)